Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Harpole

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Annals of Surgery|June 6, 2021
The Impact of Adjuvant Hemithoracic Radiation on Outcomes in Patients With Stage I-III Malignant Pleural Mesothelioma: A Dual Registry AnalysisVignesh Raman, Soraya L Voigt, Oliver K Jawitz, et al.
The Annals of Thoracic Surgery|January 23, 2003
Outcomes after esophagectomy: a ten-year prospective cohortStephen H Bailey, David A Bull, David H Harpole, et al.
The Annals of Thoracic Surgery|August 2, 2016
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung CancerPaul J Speicher, Zachary W Fitch, Brian C Gulack, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancerShakun M Malik, Richard Pazdur, Jeffrey S Abrams, et al.
Annals of Surgery|January 8, 2021
Tumor Size, Histology, and Survival After Stereotactic Ablative Radiotherapy and Sublobar Resection in Node-negative Non-small Cell Lung CancerVignesh Raman, Oliver K Jawitz, Marcelo Cerullo, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 3, 2007
Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanomaRebecca P Petersen, Steven I Hanish, John C Haney, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 12, 2015
Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancerChi-Fu Jeffrey Yang, Brian C Gulack, Lin Gu, et al.
The Annals of Thoracic Surgery|August 2, 2017
Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid TumorsKevin L Anderson, Michael S Mulvihill, Paul J Speicher, et al.
Annals of Surgery|July 11, 2020
The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal AdenocarcinomaVignesh Raman, Oliver K Jawitz, Norma E Farrow, et al.
The New England Journal of Medicine|August 11, 2006
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancerAnil Potti, Sayan Mukherjee, Rebecca Petersen, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Annals of Surgery|June 6, 2021
The Impact of Adjuvant Hemithoracic Radiation on Outcomes in Patients With Stage I-III Malignant Pleural Mesothelioma: A Dual Registry AnalysisVignesh Raman, Soraya L Voigt, Oliver K Jawitz, et al.
The Annals of Thoracic Surgery|January 23, 2003
Outcomes after esophagectomy: a ten-year prospective cohortStephen H Bailey, David A Bull, David H Harpole, et al.
The Annals of Thoracic Surgery|August 2, 2016
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung CancerPaul J Speicher, Zachary W Fitch, Brian C Gulack, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancerShakun M Malik, Richard Pazdur, Jeffrey S Abrams, et al.
Annals of Surgery|January 8, 2021
Tumor Size, Histology, and Survival After Stereotactic Ablative Radiotherapy and Sublobar Resection in Node-negative Non-small Cell Lung CancerVignesh Raman, Oliver K Jawitz, Marcelo Cerullo, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 3, 2007
Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanomaRebecca P Petersen, Steven I Hanish, John C Haney, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 12, 2015
Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancerChi-Fu Jeffrey Yang, Brian C Gulack, Lin Gu, et al.
The Annals of Thoracic Surgery|August 2, 2017
Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid TumorsKevin L Anderson, Michael S Mulvihill, Paul J Speicher, et al.
Annals of Surgery|July 11, 2020
The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal AdenocarcinomaVignesh Raman, Oliver K Jawitz, Norma E Farrow, et al.
The New England Journal of Medicine|August 11, 2006
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancerAnil Potti, Sayan Mukherjee, Rebecca Petersen, et al.
Pageof 13